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Abstract
Objectives We investigated the potential impact of reduced tobacco use scenarios on total life expectancy and health
expectancies, i.e., healthy life years and unhealthy life years.
Methods Data from the Belgian Health Interview Survey 2013 were used to estimate smoking and disability prevalence.
Disability was based on the Global Activity Limitation Indicator. We used DYNAMO-HIA to quantify the impacts of risk
factor changes and to compare the ‘‘business-as-usual’’ with alternative scenarios.
Results The ‘‘business-as-usual’’ scenario estimated that in 2028 the 15-year-old men/women would live additional
50/52 years without disability and 14/17 years with disability. The ‘‘smoking-free population’’ scenario added 3.4/2.8
healthy life years and reduced unhealthy life years by 0.79/1.9. Scenarios combining the prevention of smoking initiation
with smoking cessation programs are the most effective, yielding the largest increase in healthy life years (1.9/1.7) and the
largest decrease in unhealthy life years (- 0.80/- 1.47).
Conclusions Health impact assessment tools provide different scenarios for evidence-informed public health actions. New
anti-smoking strategies or stricter enforcement of existing policies potentially gain more healthy life years and reduce
unhealthy life years in Belgium.
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Introduction
Smoking is the leading risk factor for preventable and
premature mortality (WHO 2017). Smoking is linked to ill-
health and disability as it contributes to the pathogenesis of
several chronic diseases, such as cancer, cardiovascular
diseases and chronic respiratory diseases, and worsens
already existing medical conditions (Ostbye et al. 2002;
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Strandberg et al. 2008). The harmful impact of smoking is
mainly seen in late adulthood, but children, adolescents and
young adults may also be affected in terms of quality of life
or its length, i.e., tobacco use and secondhand smoke
exposure reduce the disability-free life expectancy (Reuser
et al. 2009; Aguilar-Palacio et al. 2018).
Health expectancies are summary measures of popula-
tion health combining morbidity and mortality into a single
indicator. Healthy life years, also known as disability-free
life expectancy, is an indicator based on limitations in daily
activities and measures how many years an individual at a
particular age is, on average, expected to live without
disability (Robine et al. 1999). Due to population aging,
increasing healthy life years is a main policy objective in
the EU and in several member states including Belgium
(Lagiewka 2012; Obyn et al. 2017; Bogaert et al. 2018).
There is, however, little evidence on how reduced tobacco
use may contribute to achieving the EU policy goal of
increasing healthy life years, as most studies focused on
effects on disease-specific incidence and mortality, overall
life expectancy, or health-adjusted life years (e.g., Holm
et al. 2014; Lhachimi et al. 2016; Singh et al. 2019).
In 2005, Belgium ratified the WHO Framework Con-
vention on Tobacco Control (WHO FCTC) (WHO 2016).
Since then, many anti-smoking policies were implemented,
and a slight but continuous reduction in the smoking
prevalence has been observed (2004: 28%; 2008: 25%;
2013: 23%) (BHIS 2018). Belgian government banned
smoking in the public and work places, restaurants, bars
and schools. In 2017, the Walloon government approved a
ban on smoking in cars in the presence of minors (children
until 16 years of age). Smoking policies enforced by the
WHO FCTC also include bans on tobacco advertising,
promotion, and sponsorship, and changes in tobacco taxa-
tion policy. Furthermore, individual and partially reim-
bursed smoking cessation support is available at both
primary care, hospitals, and health clinics. There is a toll-
free quitting hotline available for discussing smoking ces-
sation issues (WHO FCTC 2016).
Despite the recent progress in the development of
smoking prevention and cessation programs in Belgium,
the various anti-smoking laws and interventions lack a
global vision, resulting in a drop from 13th (2013) to 17th
place out of 35 European countries on the Tobacco Control
Scale 2016 (TCS) in 2016 (Joossens and Raw 2017). There
is therefore an urgent need for pro-active policy support to
enable the development of a comprehensive anti-tobacco
plan in Belgium.
In this study, we investigated the potential impact of
various reduced tobacco use scenarios on life expectancy
and health expectancies. The tobacco control scenarios
were introduced as ‘‘what-if’’ scenarios (e.g., ‘‘what if
every smoker quits smoking?’’) or as policy/intervention
scenarios (e.g., ‘‘what if a new nationwide policy is
implemented raising the legal age to buy tobacco products
from 16 to 18’’)?
We used DYNAMO-HIA 2.0.7 to quantitatively com-
pare the alternative scenarios with the ‘‘business-as-usual’’
scenario. To measure the impact on overall life expectancy
(LE) and healthy (HLY) and unhealthy (ULY) life years,
the software quantifies the effects of risk factor changes
that are initiated by newly enforced interventions and
policies. We used the tool to calculate the reduction in
HLY due to smoking and the potential gains in HLY due to
implementing new policies.
Methods
DYNAMO-HIA software
DYNAMO-HIA is a partial micro-simulation modeling
tool combining a stochastic micro-stimulation to generate
risk factor histories with a deterministic method for the
disease life table to calculate disease, disability or survival
probability. The tool applies an epidemiological model to
estimate the net transition probabilities from risk factor
prevalence, relative risk (RR) for death, and baseline all-
cause mortality, assuming that the age-specific risk factor
exposure does not change over time (Boshuizen 2010;
Lhachimi et al. 2008, 2010). While several other tools exist
for health impact assessment, as, for example, reviewed by
Fehr et al. (2016), DYNAMO-HIA offers the advantage of
being generic, flexible, and publicly available (via http://
www.dynamo-hia.eu/).
DYNAMO-HIA software estimates the health impact of
different policy scenarios over time, by comparing an
alternative scenario with the ‘‘business-as-usual’’ scenario
(Boshuizen et al. 2012; Lhachimi et al. 2012). Policies are
modeled as changes in the risk factor prevalence or as
changes in transition probabilities between the risk factor
states (Lhachimi et al. 2012).
An updated version, DYNAMO-HIA 2.0, used for the
simulation presented in this paper, models the impact of the
risk factor prevalence on disability-free life expectancy
directly by using the overall odds ratio (OR) of disability.
In this case, a hazard ratio of (other-cause) disability is
calculated by combining disability prevalence and overall
odds ratio (OR) of disability. This modeling approach
requires the following age- and gender-specific input data:
(1) Belgian data on population structure, mortality rates
and projection of newborns; (2) Belgian data on disability;
(3) smoking prevalence in Belgium; (4) OR of disability
quantifying the association between smoking and disability
and RR of death quantifying the RR of smoking on total
mortality.
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Information on smoking prevalence and disability, based
on the Global Activity Limitation Indicator (GALI), was
obtained from the Belgian Health Interview Survey 2013.
Belgian Health Interview Survey
The Belgian Health Interview Survey (BHIS) is a cross-
sectional household interview survey, conducted periodi-
cally every 4 to 5 years, that aims to collect information on
the health status of the Belgian population. Each survey
includes approximately 10,000 individuals. The detailed
methodology of the survey is described elsewhere (De-
marest et al. 2013; Scientific Institute of Public Health
2013).
In 2013, 8850 households were contacted, of which
5049 participated (57%), yielding a sample of 10,829
individuals (Van der Heyden and Charafeddine 2013).
Since the current analysis was restricted to individuals aged
15 years and older and excluded subjects with missing
information on disability and smoking, our final sample
included 6085 individuals.
Global Activity Limitation Indicator
GALI is the underlying measure of the European indicator
healthy life years (Robine et al. 2013). GALI is a single-
item survey instrument that aims to identify individuals in a
population who consider themselves as having long-term,
health-related participation restrictions or limitations in
their daily activities (Berger et al. 2014; Van Oyen et al.
2018). Three severity levels are considered: none, limited
but not severely, and severely limited. Individuals are
considered to be disabled when they report themselves as
severely limited or limited but not severely, as is com-
monly done when computing the HLY indicator (Jagger
et al. 2008; Jagger et al. 2010).
Total life expectancy (LE), healthy life years (HLY) and
unhealthy life years (ULY) are the summary measures of
population health calculated in our study. In DYNAMO-
HIA software, LE, HLY and ULY are calculated either as
cohort or cross-sectional life expectancies. Cohort life
expectancies are calculated for a simulated cohort and
based on a cohort life table that calculates the LE using
cohort-specific birth and mortality rates stratified by age
from birth (Imai and Soneji 2007). In DYNAMO-HIA, the
number of years lived in a certain health state during the
follow-up period by all the simulated individuals is sum-
med up and divided by the total number of simulated
people at baseline. Cross-sectional life expectancies are
calculated based on Sullivan’s method. Sullivan’s life
expectancy is a measure utilizing the mortality—the dif-
ference between the survival in the current year and the
next year—from a period life table. To calculate this type
of life expectancies for a particular year, DYNAMO-HIA
uses a two-step process. First, it calculates mortality in that
given year by taking the difference between the survival in
the current year and the next year. Then, it combines
mortality with disability prevalence in that year into a
period life table that is based on information from the one
calendar year. Cohort and Sullivan’s life expectancies are
calculated for individuals on one-year category up to age
95 and a 95 ? category (Boshuizen 2010).
Smoking prevalence
Age- and gender-specific smoking prevalence for individ-
uals aged 15 and above was derived from the BHIS 2013 in
a multi-step process. First, multiple fractional polynomial
models were fitted to accommodate the nonlinear associa-
tion between age (continuous) and smoking status (current,
former, never). Next, logistic regression was used to model
smoking prevalence as a function of sex and the polyno-
mial age terms, taking into account the complex survey
design (Ambler 2015; Lumley 2018). Finally, the preva-
lence of each smoking status was internally normalized, so
that three age- and sex-specific prevalence estimates sum-
med to 100%. Smoking prevalence by age and sex is shown
in Figure S1 (Online Supplement).
Disability prevalence and odds ratios
for disability
Age- and sex-specific disability prevalence and odds ratio
of disability by smoking status based on the GALI were
derived from the BHIS 2013 using logistic regression,
corrected for age (continuous) and sex and taking the
complex survey design into account. Models were fitted
separately for men and women, and correction for age
(continuous) and smoking status was included. The dis-
ability prevalence and the odds ratios are shown in Fig-
ure S2 and Table S1 (Online Supplement).
Transition probabilities
Transition probabilities of smoking, i.e., starting rates, quit
rates and restarting rates, were directly derived by
DYNAMO-HIA from the input data—i.e., smoking
prevalence, RR for all-cause mortality and baseline all-
cause mortality (Boshuizen et al. 2012). These net transi-
tion rates were estimated such that the age-specific preva-
lence of smoking remained stable over time, i.e., in the
future, the age distribution of smoking is assumed to be the
same as the current smoking distribution by age (Boshui-
zen 2010; Van de Kassteele et al. 2012).
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Relative risks of mortality
Gender-specific relative risks (RRs) of smoking on total
mortality for Belgium were obtained from a study by
Charafeddine et al. (2012). The RRs are reported in
Table S2 (Online Supplement).
Demographic information
Population size and mortality rates by age and sex for the
year 2016 were derived from Statistics Belgium (2018).
The projection of newborns between 2018 and 2050 was
derived from the United Nations World Population Pro-
spects (2017).
Simulated population
Our simulated population was based on the demographic
characteristics of real-Belgian population listed above. We
simulated 2500 individuals for each age class (0–95) and
gender. In total, our simulated population size was 480,000
individuals.
Scenarios
Potential impact of reduced tobacco use was modeled by
introducing business-as-usual and multiple ‘‘what-if’’ and
policy/intervention scenarios—characterized by either a
change in (re)start or quit transition probabilities or in
smoking prevalence. All scenarios were simulated and
compared to the reference of ‘‘business-as-usual’’ scenario
in terms of changes in healthy life years (HLY), unhealthy
life years (ULY), and life expectancy (LE) and their pro-
jected prevalence of never, current and former smokers.
The reference scenario was based on the current prevalence
of never, current and former smokers, stratified by age and
sex, and on the current transition rates between the risk
factor groups in Belgium. The reference took into account
only the currently existing smoking control policies,
without any additional interventions. All scenarios are
described in Table 1.
Results
Effect of scenarios on smoking prevalence
Short- and long-term effects of alternative scenarios on the
changes in prevalence of never, current and former
smokers by age separately for the male and female popu-
lations for 2028 are given in Fig. 1 and for 2048 in Fig-
ure S4 (Online Supplement).
In the ‘‘business-as-usual scenario,’’ the prevalence of
current smokers reflects the effect of smoking policies and
interventions already in place. In the ‘‘smoking-free-pop-
ulation’’ scenario, the prevalence of never smokers is by
definition 100% during the entire simulation period. The
‘‘zero (re)start probabilities’’ scenario, mimicking the
maximum effect of smoking prevention programs, causes a
reduction in the prevalence of current smokers as compared
to the reference scenario. By 2028, this reduction is mainly
observed among the younger ages and is mirrored by an
increase in never smokers also at younger ages. Increased
projection time allows the effect of this scenario to become
observable among the middle and higher ages as the ado-
lescents grow older and reach middle and late adulthood.
The ‘‘all smokers quit’’ scenario, mimicking the maximum
effect of smoking cessation programs, causes an immediate
reduction in the prevalence of current smokers, mirrored by
an increase in the prevalence of former smokers when
compared to the ‘‘business-as-usual scenario.’’ This
reduction in prevalence of current smokers is greater in the
first years after the intervention and becomes stable after
30 years. By definition, this scenario does not affect the
prevalence of never smokers. The same trend is observed in
the short and long run. The ‘‘no smoking initiation before
age 18’’ scenario reduces the prevalence of smokers among
adolescents slightly, keeping this trend constant over time.
The ‘‘30% increase in quit probabilities’’ scenario causes
initially a small reduction in the prevalence of smokers at
all ages but with time, larger reduction is observed in late
adulthood. Similar pattern but more pronounced is
observed for the ‘‘doubling quit probabilities’’ scenario.
Effect of scenarios on healthy life years,
unhealthy life years and life expectancy
We investigated the impact of the scenarios on the cross-
sectional life expectancies for men and women at the age
of 15 in 2028 and 2048 (Table 2).
The ‘‘business-as-usual’’ scenario shows that in 2028
and 2048, 15-year-old men/women are expected to live
additional 50/52 years without disability and 14/17 years
with disability.
In comparison with the reference scenario, in 2028 for
the male/female population, the ‘‘smoking-free popula-
tion’’ scenario would result in an increase in HLY by 3.4/
2.7 years, a decrease in ULY by 0.79/1.9 years and an
increase in total LE by 2.7/0.86 years. By 2048, these
differences become even more pronounced—HLY would
increase by 3.5/2.9 years, ULY would decrease by 0.76/
1.9 years and LE would increase by 2.8/0.98 years in
men/women. For a cohort of 15-year-olds in 2018, the
same scenario of absence of current and former smokers
also results in maximum gains in terms of HLY and total
M. Otavova et al.
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LE: about 3.6 years in HLY and 2.8 years in overall LE in
males and 2.8 years in HLY and 0.98 years in overall LE
in women (Online Supplement). If Belgium had smoking
prevalence of Sweden, the European country with the
lowest smoking prevalence, the gain in terms of HLY and
the reduction in ULY would be substantial for both genders
in both reported years. For the 15-year-old male/female in
2028, HLY would increase by 0.92 and 0.17 years, ULY
would decrease by 0.57 and 0.40 years. By 2048, the
increase in HLY would be greater for both sexes, while an
additional decrease in ULY would be observed for females
only.
The highest gains among all ‘‘what-if’’ scenarios were
reported for the ‘‘zero (re)start probabilities and all smok-
ers quit’’ scenarios. In 2028, men would gain 1.9/1.1 years
in HLY and LE and lose 0.80 years in ULY; women would
gain 1.7/0.20 years in HLY and LE and lose 1.5 years in
ULY. By 2048, this alternative scenario would gain 2.3/
2.0 year in HLY for men/women and lose 0.93/1.7 years in
ULY in men/women, respectively.
By increasing the quit probabilities by 30%, HLY would
increase by 0.1/0.26 years for men by 2028 and 2048. For
women, these differences would be 0.12/0.21 years by
2028/2048, respectively. Doubling the quit probabilities
yields an increase of 0.40/0.34 years in HLY for men/-
women by 2028; the gains in HLY further increase up to
0.68/0.57 years for men/women by 2048. In both scenarios
and for both sexes, ULY decreases gradually over time
with an increase in quit probabilities. Although the gain in
HLY is greater among males, the reduction in ULY is more
notable among females. If the legal age of smoking rose
from 16 up to 18, HLY would increase by 0.03 and
0.05 years, and ULY would decrease by 0.02 and 0.04 in
2028 for men/women. In 2048, only a slight increase in
HLY and a decrease in ULY for women and almost no
change for men would be observed.
Table 1 Overview of reduced tobacco use scenarios and their comparison to the reference scenario
Scenario Definition
Reference
‘‘Business-as-usual’’ scenario Current prevalence of never, current and
former smokers, current transition rates
between the risk factor groups and
current existing smoking control
policies in Belgium
Change compared to the reference
scenario
Gains compared to the reference scenario
‘‘What-if’’ scenarios
1. Smoking-free population Population consists of never smokers only Quantification of full burden of smoking on the
overall population health
2. Zero (re)start probabilities (Re)start chances equal 0% Maximum gains from smoking initiation
interventions
3. All smokers quit Quit chances equal 100% Maximum gains from smoking cessation
interventions
4. Zero (re)start probabilities
and all smokers quit
(Re)start chances equal 0%
Quit chances equal 100%
Maximum gains from smoking initiation and
smoking cessation interventions combined
5. Smoking prevalence in
Sweden
Prevalence of never, current and former
smokers in Sweden in 2016
Quantification of the health burden of smoking if
the smoking prevalence in Belgium matched
the one of Sweden, a country with the lowest
smoking prevalence in Europe according to
OECD (OECD 2016)
Policy/intervention scenarios
6. No smoking initiation
before age 18
Zero smoking prevalence below age 18 Maximum gains from raising the minimum age
for purchase of tobacco from 16 to 18 years
7. 30% increase in quit
probabilities
Quit chances are multiplied by 1.3 The lower bound of an increase in quit
probabilities if the smoking quit interventions
are provided by medical personnel (Grignon
and Reddock 2012)
8. Doubling quit probabilities Quit chances are multiplied by 2.0 Quantification of the effect size of smoking
cessation interventions as found in literature
review (Lemmens et al. 2008; Levy et al. 2010;
Minary et al. 2013)
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Fig. 1 Smoking prevalence by
age and gender. Effect of
different reduced tobacco use
scenarios in Belgium, 2028
Table 2 Impact of reduced
tobacco use scenarios on
healthy life years (HLY),
unhealthy life years (ULY) and
overall life expectancy (LE) (in
years) for men and women at
the age of 15 in 2028 and 2048
HLY ULY LE
2028 2048 2028 2048 2028 2048
Men
Reference scenario 50.07 49.97 14.04 14.01 64.11 63.98
Difference with reference scenario
1. Smoking-free population 3.44 3.54 - 0.79 - 0.76 2.65 2.78
2. Zero (re)start probabilities 0.53 1.59 - 0.26 - 0.75 0.27 0.84
3. All smokers quit 1.73 1.74 - 0.72 - 0.74 1.01 1.00
4. Zero (re)start probabilities and all smokers quit 1.88 2.25 - 0.80 - 0.93 1.08 1.32
5. Smoking prevalence of Sweden 0.92 1.03 - 0.57 - 0.56 0.35 0.47
6. No smoking initiation before age 18 0.03 0.03 - 0.02 - 0.01 0.01 0.02
7. 30% increase in quit probabilities 0.14 0.26 - 0.04 - 0.09 0.10 0.17
8. Doubling quit probabilities 0.40 0.68 - 0.14 - 0.25 0.26 0.43
Women
Reference scenario 51.65 51.51 17.32 17.34 68.97 68.85
Difference with reference scenario
1. Smoking-free population 2.74 2.88 - 1.88 - 1.90 0.86 0.98
2. Zero (re)start probabilities 0.50 1.44 - 0.43 - 1.23 0.07 0.21
3. All smokers quit 1.55 1.58 - 1.37 - 1.40 0.18 0.18
4. Zero (re)start probabilities and all smokers quit 1.67 1.98 - 1.47 - 1.68 0.20 0.30
5. Smoking prevalence of Sweden 0.17 0.32 - 0.40 - 0.45 - 0.23 - 0.13
6. No smoking initiation before age 18 0.05 0.06 - 0.04 - 0.05 0.01 0.01
7. 30% increase in quit probabilities 0.12 0.21 - 0.09 - 0.18 0.03 0.03
8. Doubling quit probabilities 0.34 0.57 - 0.29 - 0.49 0.05 0.08
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The impact of ‘‘what-if’’ scenarios and smoking policy/
interventions on the cohort life expectancies led to similar
conclusions as for the impact on cross-sectional life
expectancies (Table S3 Online Supplement).
Discussion
To our knowledge, this is the first Belgian study aiming to
compare how various reduced tobacco use scenarios may
affect the length of HLY, ULY and overall LE of the
Belgian population as a result of scenarios linked changes
in the prevalence of current, former and never smokers.
The comparison was made using DYNAMO-HIA, a
dynamic population model for simulating the projection of
real-life Belgian population for a period of 30 years to the
future, separately for men and women (Lhachimi et al.
2012).
Our findings confirm results of prior studies that
smoking is one of the main risk factors for disability and
premature mortality in the male and female population both
in international research and in publications with focus on
Belgium (Brønnum-Hansen and Juel 2001; Ferrucci et al.
1999; Reuser et al. 2009; Van Oyen et al. 2014; Yokota
et al. 2018). As most of our scenarios model maximum
health gains, we provide valuable guidance to policy
makers on which measures potentially have the highest
impact. Furthermore, our study provides novel information
on how reduced tobacco use can contribute to achieving the
EU policy goal of increasing the number of HLYs
(Lagiewka 2012).
Comparisons of modeled reduced tobacco use scenarios
with the reference scenario indicate that the gains in HLY
or LE and the reduction in ULY or in smoking prevalence
differ in each scenario and over the projection period. The
‘‘smoking-free population’’ scenario demonstrates the
greatest increase in HLY and LE and the greatest reduction
in ULY for both genders among all scenarios; this scenario
is, however, not realistically achievable, but rather reflects
the current population level impact of tobacco use. The
impact under the ‘‘zero (re)start probabilities’’ scenario is
built up over time and is more effective in the future than in
the short run. Interventions preventing smoking initiation
mainly focus on never smokers among adolescents who
possess low absolute risks of disability and mortality, and
hence, their gains in terms of health are more observable in
further future as the adolescents reach later adulthood.
The smoking control policies focusing on smoking
cessation, maximized in the ‘‘all smokers quit’’ scenario,
result in larger gains in HLY and LE in the first years after
the interventions are implemented and their effect size
remains almost constant over the next 30 years. These
results confirm the findings by Kulik et al. (2012) that
intervention/policies targeting smoking cessation are more
effective in the short and long term than programs focusing
on the prevention of smoking initiation.
Our results showed that policy/intervention methods
combining prevention of smoking initiation with smoking
cessation programs are the most effective among all the
alternative scenarios, yielding the largest decrease in the
smoking exposure and in ULY as well as the largest
increase in HLY and total LE. The reduction in ULY is
even greater for the ‘‘zero (re)start probabilities and all
smokers quit’’ scenarios than for the ‘‘smoking-free pop-
ulation’’ scenario between the years 2018 and 2048 in the
male population. A possible explanation is that individuals
in the smoking-free population without any smoking his-
tories accumulate more ULYs over their prolonged overall
life course than individuals in a population consisting of
never and former smokers. The fact that a combination of
two different potential strategies for eradication of smoking
is the most effective one is supported by findings from
Rose that policies targeting the whole population are often
the most effective ones (2001).
Our results indicate that an implementation of a
nationwide policy raising the legal age limits to buy
tobacco products from 16 to 18 would only result in a
negligible reduction in smoking prevalence among young
people and in turn to an increase in HLY and LE. These
claims support findings of Fidler and West who investi-
gated the impact on smoking prevalence after raising the
minimum age of legal access to tobacco products from 16
to 18 in 2007 in England (2010). As adolescence is a
sensitive developmental period, many risk factor behaviors
peak during this time (Office of the Surgeon General 2012).
Preventing young people from experimenting with tobacco
products when they are the most vulnerable should become
priority of the policy makers in the government.
Strengths and limitations
An important strength of our study is the use of nationally
representative data from the Belgian population. Added
value to this study also includes the use of disability
indicator based on the GALI, allowing better comparability
with international studies that use the same instrument. The
key strength of our study relates to the use of a dynamic
modeling tool exclusively developed for health impact
assessment. DYNAMO-HIA software can distinguish dif-
ferent risk factor states in order to generate transition
probabilities between these states necessary for modeling
the impacts of various interventions/policies on population
health.
Our study has several limitations that must be consid-
ered when interpreting the results. Self-reported data on
disability and smoking behavior were obtained from cross-
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sectional survey, and thus, assessing the causal relationship
between smoking and disability prevalence may result in a
temporal bias. Also, selection bias and underestimating of
the true smoking exposure may have occurred in the BHIS
2013 and be further aggravated by the exclusion of indi-
viduals with missing information on smoking or the GALI.
The BHIS 2013 did not provide information on time
since quitting for the former smokers; hence, the OR
quantifying the association between smoking and disability
does not take into account such information. Prior studies
report conflicting findings on the impact of smoking ces-
sation on disability. Some suggest that former smokers
have similar disability hazards as current smokers, while
others suggest that the smoking duration and time since
quitting significantly affect the health-related quality of life
and need to be considered (Ostbye et al. 2002; Reuser et al.
2009; Sarna et al. 2008).
We calculated health expectancies by Sullivan’s
method. This approach assumes constant transition rates
between disability states and in case of rapid and sudden
changes in the observed period may lead to biased results
(Sullivan 1971). Prior studies showed that the Sullivan
method cannot detect sudden changes in disability transi-
tion rates, but can still provide good estimates if the
changes in disability prevalence are smooth and relatively
regular over longer period of time (Mathers 1997). When
comparing the results with the cohort life table approach,
however, conclusions appeared to the robust.
The main drawback of our study is the lack of uncer-
tainty quantification provided by DYNAMO-HIA. In its
current form, the software does not include probabilistic
sensitivity analysis as its implementation into the model
would be time-consuming and cost intensive.
Conclusions
Our findings provide a better understanding of how a
reduction in tobacco use may affect HLY, ULY and LE.
We showed that the nationwide anti-smoking policies/in-
terventions, combining the prevention of smoking initiation
with the smoking cessation programs, are the most bene-
ficial in reducing smoking prevalence and in turn increas-
ing HLY and decreasing ULY in both the short and long
runs. Future research should explore the role of frequency
of smoking and time since quitting in the impact of tobacco
control interventions on health expectancies. Nonetheless,
we can conclude that all modeled scenarios reduce the
prevalence of smoking and prolong the years without
disability.
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